Institutions / SilverArc Capital Management, LLC
SilverArc Capital Management, LLC
CIK 1816307 · Institution · as of Dec 31, 2025
Portfolio value
$691.15M
Positions
64
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 64 →
| Company | Value | % of portfolio |
|---|---|---|
| Abivax SA | $56.93M | 8.2% |
| Cogent Biosciences, Inc. | $44.23M | 6.4% |
| Urogen Pharma Ltd | $40.72M | 5.9% |
| KalVista Pharmaceuticals Inc | $39.20M | 5.7% |
| Celcuity Inc.CELC | $37.42M | 5.4% |
| Nuvalent, Inc. | $31.33M | 4.5% |
| Dianthus Therapeutics, Inc. | $30.91M | 4.5% |
| Kodiak Sciences Inc.KOD | $28.61M | 4.1% |
| Praxis Precision Medicines, Inc. | $24.31M | 3.5% |
| Immunome Inc. | $24.19M | 3.5% |
| Fractyl Health, Inc.GUTS | $21.65M | 3.1% |
| Monte Rosa Therapeutics, Inc. | $16.14M | 2.3% |
| Veracyte Inc | $15.05M | 2.2% |
| CG Oncology, Inc. | $15.00M | 2.2% |
| Rhythm Pharmaceuticals, Inc. | $14.55M | 2.1% |
| Syndax Pharmaceuticals Inc | $13.51M | 2.0% |
| Biogen Inc. | $13.27M | 1.9% |
| Insmed Inc | $12.40M | 1.8% |
| Centessa Pharmaceuticals PLC | $11.46M | 1.7% |
| Viridian Therapeutics, Inc. | $10.85M | 1.6% |
| Ascendis Pharma A/S | $10.50M | 1.5% |
| Pfizer Inc | $10.44M | 1.5% |
| Benitec Biopharma Inc.BNTC | $9.86M | 1.4% |
| Avalo Therapeutics, Inc. | $9.52M | 1.4% |
| Guardant Health, Inc. | $9.39M | 1.4% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.